RT Journal Article
SR Electronic
T1 Response to Comment on “A small-molecule antivirulence agent for treating <em>Clostridium difficile</em> infection”
JF Science Translational Medicine
FD American Association for the Advancement of Science
SP 370tr2
OP 370tr2
DO 10.1126/scitranslmed.aaf3410
VO 8
IS 370
A1 Bender, Kristina Oresic
A1 Garland, Megan
A1 Bogyo, Matthew
YR 2016
UL http://stm.sciencemag.org/content/8/370/370tr2.abstract
AB Ebselen’s antivirulence activity in Clostridium difficile infection is likely due to multiple modes of action, but the contribution of each to its efficacy remains unclear.